Ignite Creation Date:
2024-05-06 @ 9:17 AM
Last Modification Date:
2024-10-26 @ 12:12 PM
Study NCT ID:
NCT02942290
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-05
First Post:
2016-10-18
Brief Title:
A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes MDS
Sponsor:
AbbVie
Organization:
AbbVie
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01-12
Start Date Type:
ACTUAL
Primary Completion Date:
2027-01-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-01-08
Completion Date Type:
ESTIMATED
First Submit Date:
2016-10-18
First Submit QC Date:
October 20 2016
Study First Post Date:
2016-10-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-02
Last Update Post Date:
2024-07-05
Last Update Post Date Type:
ACTUAL